This page is a permanent link to the reply below and its nested replies. See all post replies »
Graylight · 51-55, F
WOW, that is so cool. It has nothing to do with Covid-19. SARS is not Covid-19.
Let's start at the beginning:
Here, this might help: https://www.healthline.com/health/coronavirus-vs-sars#whats-a-coronavirus
The article goes on to state:
This from a meta analysis (a study that examines all previous studies on a topic):
Let's start at the beginning:
"chloroquine has strong antiviral effects on SARS-CoV infection of primate cells."
This according to the study. This is a preliminary study on which subsequent research was based. That subsequent research yielded negative results for Covid-19. Here, this might help: https://www.healthline.com/health/coronavirus-vs-sars#whats-a-coronavirus
The article goes on to state:
"Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available."
This from a meta analysis (a study that examines all previous studies on a topic):
In conclusion, although we could not draw a clear conclusion for the recommendation of potential therapies for COVID-19 considering the very low quality of evidence and wide heterogeneity of interventions and indications, our results may help clinicians to comprehensively understand the advantages and drawbacks of each anti-coronavirus agents on efficacy and safety profiles. Lopinavir/ritonavir combinations might observe better virological eradication capability than other anti-coronavirus agents. Conversely, ribavirin might cause more safety concerns especially bradycardia. Thus, large RCTs objectively assessing the efficacy of antiviral therapies for SARS-CoV-2 infections should be conducted with high priority.
https://www.sciencedirect.com/science/article/pii/S1043661820311804